Skip to content

Faculty profile

Rachel Tyndale

Back to faculty
ProfessorDepartment of Pharmacology and ToxicologyUniversity of Toronto

Latest papers

  • Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression.

    Journal of affective disorders · 2024

  • Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes.

    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020

All 2 publications

Latest funding

  • The SWAGAT Study: Smoking cessation and Weight gain Attenuation with dual Glucagon like Peptide Receptor & Gastric Inhibitory Receptor Agonist- Tirzepatide: A double blinded RCT.

    CIHR · 2026 · Co-investigator

    $100,000
  • Impact of Genomic Factors in Accidental Lethal Opioid Overdose

    CIHR · 2025 · Co-investigator

    $726,750
  • A Phase II Multi-Site, Double-Blind, Randomized, Sham-Controlled, Clinical Trial of Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder

    CIHR · 2025 · Co-investigator

    $1,468,800
All 32 grants and awards

Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction